Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
12-CdA, 2-chloro-2'-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
22-CdA, 2-chloro-2'-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
32-CdA, 2-chloro-2?-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
42-CdA, 2-chloro-2?-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
52-CdA, 2-chloro-2’-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
62-CdA, 2-chloro-2’-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
72-chloro-2'-deoxy-beta-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
82-chloro-2'-deoxy-ß-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
92-chloro-2?-deoxy-beta-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
102-chloro-2?-deoxy-ß-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
112-chloro-2’-deoxy-beta-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
122-chloro-2’-deoxy-beta-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
132-chloro-2’-deoxy-ß-D-adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
142-chloro-2’-deoxy-ß-D-adenosine (2-CdA)[2] Adenosine,
Cladribine		[2] Adenosine ,
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[18] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
15Adenosine[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 13, 58, 65 💬
16Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)[1] Adenosine[1] Adenosine 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬